MBA Roundup: Snoop Dogg Named USC Marshall Commencement Speaker

USC Marshall Students

Snoop Dogg Named USC Marshall Commencement Speaker

USC Marshall: “Entertainment icon, entrepreneur, and philanthropist Snoop Dogg, will be the 2025 commencement speaker for USC Marshall School of Business.

For nearly three decades, Snoop Dogg has been a trailblazing force, consistently raising the bar as a globally recognized innovator. Pulling from his experience as a multi-platinum rapper, singer, songwriter, actor, record producer, DJ, and media personality, the multi-hyphenate entrepreneur will share with graduates knowledge and life lessons earned across his groundbreaking career.

“I am deeply honored to join USC Marshall’s commencement in celebrating the remarkable achievements of these graduates,” Snoop Dogg said. “Commencement is not just a milestone — it’s a launching point. It’s about stepping into your purpose, applying what you’ve learned, and making an impact that matters. I look forward to welcoming them into the next chapter of their journey as leaders, innovators, and changemakers.”

To read more, click here.

DON’T MISS: MEET USC MARSHALL’S MBA CLASS OF 2025


ddd

Seattle’s Albers School Names New Dean

University of Seattle: “From Husky to Redhawk, Seattle University has named Dr. Daniel Turner as the next Dean of the Albers School of Business and Economics. Currently, Dr. Turner is the Brix Endowed Fellow in Marketing and Associate Dean at the University of Washington’s Foster School of Business. He will begin at SU on July 1, 2025.

Dr. Turner replaces Joseph Phillips, PhD, who has served as Albers Dean for the past 24 years.

Seattle University Provost Shane P. Martin describes Dr. Turner as an accomplished educator, higher education administrator and consultant.

“He has a strong record as a values-driven, strategic and collaborative leader who prioritizes innovation and a growth mindset,” Martin says.

At Washington, Dr. Turner teaches Strategic Marketing Management, Pricing and Marketing of Innovations courses in various MBA and executive education programs, receiving several teaching awards including the Foster School’s PACCAR Award for Teaching Excellence.

As Associate Dean for the master’s programs, Dr. Turner drives the strategic direction of graduate education, overseeing admissions, curriculum, operations, career management and alumni relations for Foster’s seven MBA programs and six specialized master’s degrees.”

To read more, click here.

DON’T MISS: UNDER THE RADAR: SEATTLE ALBERS’ BUSINESS ANALYTICS PROGRAM PREPARES STUDENTS FOR DATA-DRIVEN CAREERS


Wharton Rebrands Its DEI Concentration

Wharton School: “The Wharton School’s undergraduate concentration and MBA major in diversity, equity, and inclusion were both renamed to Leading Across Differences.

The name change comes in the wake of a comprehensive removal of references to DEI from Penn’s websites and schools — including Wharton — following an executive order from 1968 Wharton graduate and President Donald Trump that required federally funded universities such as Penn to end any DEI programs that could be in violation of federal civil rights laws. According to website archives, the change was made sometime after March 16.

“The new name reflects the broader scope of the concentration/major following the addition of new courses and conveys its core intent, which is to teach students how to effectively work with and lead people with different perspectives and backgrounds,” a Wharton spokesperson wrote to The Daily Pennsylvanian.”

To read more, click here.

DON’T MISS: AACSB FACES A SOCIAL MEDIA BACKLASH OVER DROPPING DIVERSITY GUIDELINES


Emlyon business school in France has an MBA portfolio that is built upon the school’s hands-on pedagogy, entrepreneurial roots, and deep commitment to sustainability. With online and part-time options, it is also highly flexible.

EMLYON Launches A Double Degree In Partnership With UCL Global Business School For Health

EMLYON Business School: “EMLYON Business School and the UCL Global Business School for Health (UCL GBSH) have launched a dual master’s degree in Biotech and Pharmaceutical Management — set to start in September 2025.

The partnership combines emlyon’s business expertise with UCL GBSH’s management approach in healthcare leadership to create a comprehensive educational pathway for future health sector leaders. This will be available to students enrolled in emlyon’s two-year BioPharma curriculum within the Master in Management (MiM) programme.

Students will begin with a year at emlyon’s Lyon campus, located in a vibrant life sciences ecosystem — a hub for biotechnologies and pharmaceuticals — and focus their studies on biopharma economics through specialised courses delivered by faculty and industry experts from research centres, biotech ventures, and pharmaceutical companies. The emlyon MiM programme ranks eighth worldwide in the 2024 Financial Times Master in Management ranking and second for employability among French business schools.”

To read more, click here.

DON’T MISS: ‘LEARNING BY DOING’: EMLYON’S MBA IS HANDS-ON, ENTREPRENEURIAL & SUSTAINABLE